Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Leading Edge Materials' Investor Update and Significant Activities (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Dri Healthcare Trust
T.DHT.UN
Alternate Symbol(s):
DHTRF
Healthcare
Biotechnology
DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio...
includes Empaveli/Syfovre, Eylea I, Eylea II, Ilaris, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Simponi, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, sebetralstat, and others. Its therapeutic areas include hematology, ophthalmology, influenza, endocrinology, dermatology, oncology, neurology, immunology, lysosomal storage disorder, hereditary angioedema, and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:DHT.UN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(6309)
•••
retiredcf
X
Post by
retiredcf
on Mar 04, 2025 9:15am
CIBC
Currenty have an $18.00 target. GLTA EQUITY RESEARCH March 3, 2025 Flash Research DRI HEALTHCARE TRUST Q4/24 First Look: Orserdu Milestones & Outperformance Drive Notable Beat Our Conclusion
...more
(6309)
•••
retiredcf
X
Post by
retiredcf
on Mar 04, 2025 8:43am
Strong Results (RBC)
March 3, 2025 DRI Healthcare Trust Q4/24 - Strong results aided by Orserdu royalties; Quarterly dividend increased to $0.10/ unit (+18%) TSX
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 03, 2025 5:30pm
New Press Release - DRI Healthcare Trust Reports Fourth Quarter and Annual 2024 Results
Remediation of material weaknesses complete 45% increase in Normalized Total Cash Receipts over the prior year showcases continued execution and growth of portfolioAnnouncing 2025 royalty income guidance of $172 to $182 million, excluding milestone income and any new transactions, and increase in...
read article.
(6309)
•••
retiredcf
X
Post by
retiredcf
on Mar 02, 2025 9:26am
Assessment
DHT.UN is cheap, and has stabilized. The former 'expense misappropriation' of the CEO was certainly a red flag for us. But he has been replaced, and the company is back on track. Cash flow is
...more
(6309)
•••
retiredcf
X
Post by
retiredcf
on Feb 25, 2025 11:29am
RBC
Their upside scenario target is $21.00. GLTA February 25, 2025 Outperform TSX: DHT-U; CAD 11.93 Price Target CAD 17.00
...more
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Feb 22, 2025 2:18pm
RE:RE:RE:Top Pick
Thx retiredcf. He misspoke -- capital heavy business ofc, very light leverage. Perhaps he meant in the sense of bricks and mortar investment. Very high margins indeed, and getting
...more
(6309)
•••
retiredcf
X
Comment by
retiredcf
on Feb 22, 2025 12:38pm
RE:RE:Top Pick
TOP PICK DRI Healthcare Trust(DHT.UN-T) 21/02/2025 Applied similar royalty approach from mining sector to pharmaceutical business. Allows for new development in pharmaceutical business. Capital light
...more
(6309)
•••
retiredcf
X
Comment by
retiredcf
on Feb 21, 2025 3:59pm
RE:Top Pick
Second stock in the clip; this is the only one that he and his family also own personally. GLTA https://www.bnnbloomberg.ca/video/shows/market-call/2025/02/21/jerome-hass-top-picks-mainstreet-equity
...more
(12)
•••
raybay_98
X
Comment by
raybay_98
on Feb 21, 2025 1:53pm
RE:Top Pick
You forgot to add, National Bank just reduce their target price to $17.50 from $19.50 and maintained their Ouperform Rating! jmho
(6309)
•••
retiredcf
X
Post by
retiredcf
on Feb 21, 2025 1:04pm
Top Pick
Second one today from Jerome Haas who hasn't been on Market Call since 2017. A misunderstood company that is incredibly cheap at only 1.3 x BV. Consensus is 10/10 Buys with a target of $18.84
...more
(12)
•••
raybay_98
X
Comment by
raybay_98
on Feb 10, 2025 3:15pm
RE:New Sebetralstat Data
As the old saying goes, 'flogging a dead horse'. jmho.
(70)
•••
SONOFFERGUS
X
Post by
SONOFFERGUS
on Feb 10, 2025 9:17am
New Sebetralstat Data
https://ir.kalvista.com/news-releases/news-release-details/kalvista-pharmaceuticals-presents-new-sebetralstat-data-western To my untrained eye, this is very positive news for DHT. KALV stock was
...more
(6309)
•••
retiredcf
X
Post by
retiredcf
on Jan 31, 2025 1:34pm
Tariffs
The Canadian dollar spiked at midday Friday after a Reuters report suggested that U.S. President Donald Trump will announce new tariffs against Canada and Mexico that will begin on March 1. The
...more
(12)
•••
raybay_98
X
Comment by
raybay_98
on Jan 29, 2025 11:36am
RE:RE:RE:RPRX pops 15% on news of internalizing manager and buyback
"I sent an email to RPRX encouraging them to give it a look if they aren't already." IMHO, to bad your the only one who appears to being doing something!
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
ReGen III: Pioneering a Cleaner Lubricants Future with Patented Re-Refining
Have you held units of a TD mutual fund through a discount broker? Learn more.